All In MedTech

FDA Clearance Tracker · P960009-S156

MEDTRONIC DEEP BRAIN STIMULATION (DBS) THERAPY

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Sep 13, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Sep 13, 2013

Approved

Time to decision

378 days

Received Aug 31, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P960009-S156
Device name
MEDTRONIC DEEP BRAIN STIMULATION (DBS) THERAPY
Applicant location
Minneapolis, MN
Received
Aug 31, 2012
Decided
Sep 13, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P960009

Device type

Device class
Class III

Every decision under product code MHY

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN UPDATE TO YOUR LABELING.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.